Personalized medicine in Africa is steadily advancing as companies invest in genomics, molecular diagnostics, and data-driven healthcare solutions tailored to local populations.
Rather than relying solely on imported data and foreign testing systems, several Africa-based firms are building regional capacity to improve diagnosis, treatment selection, and clinical research across the continent.
Here are five Africa-focused companies actively contributing to personalized medicine and genomic testing:
— Syndicate Bio (Nigeria) provides genomic solutions and precision medicine access, offering clinical sequencing and multi-omics services designed to support research and individualized healthcare decisions.
— Revna Biosciences (Ghana) operates as a precision medicine and molecular diagnostics company, applying advanced laboratory technologies to support disease detection and research across West Africa.
— PathCare (South Africa) is a major pathology laboratory group offering molecular diagnostics and genetic testing services that contribute to personalized treatment planning.
— Inqaba Biotec (South Africa, multi-country footprint) delivers genomics and sequencing services across Africa, supporting research institutions, healthcare providers, and biotechnology initiatives in precision medicine workflows.
— Sanger Molecular Diagnostics (Nigeria) provides molecular and genetic diagnostic services aimed at strengthening personalized healthcare delivery within Nigeria and the broader West African region.
Together, these companies reflect the growing infrastructure behind personalized medicine in Africa. By expanding genomic testing capacity, molecular diagnostics, and research collaboration, they are contributing to more tailored and data-driven healthcare solutions aligned with the continent’s unique genetic diversity.
Methodology: Companies included are Africa-headquartered or Africa-operational entities actively providing genomics, molecular diagnostics, or precision medicine services as of 2025.
Image Credit: Freepik
